PFG Investments’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$392K Buy
84,859
+1,020
+1% +$5.05K 0.02% 799
2026
Q1
$388K Buy
83,839
+883
+1% +$4.61K 0.02% 721
2025
Q4
$415K Buy
82,956
+779
+0.9% +$4.05K 0.02% 645
2025
Q3
$417K Buy
82,177
+658
+0.8% +$2.9K 0.02% 617
2025
Q2
$351K Sell
81,519
-11,495
-12% -$56.8K 0.02% 666
2025
Q1
$561K Sell
93,014
-2,993
-3% -$15.1K 0.04% 452
2024
Q4
$379K Buy
96,007
+17,167
+22% +$76.9K 0.02% 608
2024
Q3
$461K Sell
78,840
-6,768
-8% -$33.4K 0.03% 525
2024
Q2
$369K Sell
85,608
-3,048
-3% -$14.6K 0.03% 565
2024
Q1
$417K Buy
+88,656
New +$339K 0.03% 604
2023
Q4
Sell
-30,663
Closed -$167K 517
2023
Q3
$167K Sell
30,663
-2,300
-7% -$18.4K 0.03% 469
2023
Q2
$305K Buy
32,963
+7,812
+31% +$66.1K 0.05% 365
2023
Q1
$207K Buy
+25,151
New +$278K 0.04% 432

Other funds holding MPT

PFG Investments's MPT Position: Q2 2026 in Review

PFG Investments increased its Medical Properties Trust (MPT) stake by 1.2% in Q2 2026, buying an estimated $5.05K and bringing the position to 84,859 shares worth $392K. The position accounts for 0.02% of the portfolio, ranked #799.

PFG Investments first reported a position in MPT in Q1 2023 and has held it in 13 quarters since. The position peaked at $561K in Q1 2025. 158 funds tracked by Wall St. Rank hold MPT as of Q2 2026.

  • PFG Investments held 84,859 shares of Medical Properties Trust worth $392K as of Q2 2026.
  • PFG Investments bought 1,020 Medical Properties Trust shares in Q2 2026, an estimated $5.05K.
  • Medical Properties Trust made up 0.02% of PFG Investments's portfolio in Q2 2026, its #799 holding.
  • PFG Investments first reported a position in Medical Properties Trust in Q1 2023 and has held it in 13 quarters since.
  • PFG Investments's Medical Properties Trust position peaked at $561K in Q1 2025.
  • 158 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.